We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current RVMD market cap is 7.39B. The company's latest EPS is USD -2.5940 and P/E is -0.06.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 742k | 0 | 0 | 0 |
| Operating Income | -123.25M | -179.98M | -140.86M | -156.64M | -175.71M |
| Net Income | -108.43M | -161.54M | -116M | -133.23M | -156.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 50.04M | 42.98M | 29.39M | 35.38M | 11.58M |
| Operating Income | -54.12M | -110.7M | -188.01M | -258.28M | -487.19M |
| Net Income | -61.9M | -110.38M | -187.09M | -248.71M | -436.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 984.23M | 2.06B | 1.91B | 1.81B | 1.76B |
| Total Liabilities | 146.77M | 235.51M | 182.9M | 189.59M | 196.7M |
| Total Equity | 837.46M | 1.83B | 1.73B | 1.62B | 1.57B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 220.53M | 567.4M | 737.99M | 811.93M | 2.06B |
| Total Liabilities | 67.99M | 92.73M | 135.42M | 126.74M | 235.51M |
| Total Equity | -152.57M | 474.68M | 602.57M | 685.19M | 1.83B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -230.01M | -350.57M | -160.56M | -288.73M | -419.15M |
| Investing | 37.8M | -342.6M | -247.97M | -140.02M | -161.49M |
| Financing | 389.85M | 1.23B | 810k | 8.31M | 85.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -49.62M | -100.06M | -147.18M | -224.4M | -350.57M |
| Investing | -101.97M | -234.23M | -142.12M | -24.12M | -342.6M |
| Financing | 98.66M | 422.78M | 294.18M | 301.43M | 1.23B |
| Market Cap | 7.39B |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 2.33 |
| Price to Cash Ratio | 0.04 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 168.22M |
| Average Volume (1 week) | 1.71M |
| Average Volume (1 Month) | 2.22M |
| 52 Week Change | 58.53% |
| 52 Week High | 62.40 |
| 52 Week Low | 25.93 |
| Spread (Intraday) | 4.12 (8.74%) |
| Company Name | Revolution Medicines Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.revmed.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
